medigraphic.com
ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)

2012, Number 4

<< Back Next >>

Evid Med Invest Salud 2012; 5 (4)

Spirometry as a tool in detecting alterations in the respiratory function. A World Spirometry Day report

Velázquez CE, Che MJL, Cortés-Télles A

Language: Spanish
References: 22
Page: 124-130
PDF size: 197.13 Kb.


ABSTRACT

Introduction: The initiative “2010, the Year of the Lung” promoted the World Spirometry Day (WSD) with the determination to encourage early detection of respiratory diseases. This paper aims to report the results of spirometry tests performed in the state of Yucatan during the said WSD. Material and Methods: Cross-sectional study that includes data from spirometry tests performed in adults between 20 and 80 years old without any previously diagnosed respiratory disease; in addition, without inhaled corticosteroid nor bronchodilators and in absence of acute respiratory illness within 4 weeks.Results: 91 participants with 91 spirometry tests were included. The age median was 40 years, with an interquartile (IQR) of 30-53 and 56% were female. According to international standardized guidelines, 30% of all tests showed an abnormal pattern in lung function, of these, 33% with airflow obstruction and the severity ranged between mild and moderately severe.Conclusions: In a group of people from the state of Yucatan the percentage of abnormal tests was significant. We must keep promoting the spirometry during the initial evaluation of respiratory diseases


REFERENCES

  1. World Health Organization. Chronic Respiratory Diseases (Consultado el 18 de agosto 2012). Available in: http://www.who.int/respiratory/en/html

  2. Vargas-Domínguez C, Gochicoa-Rangel L, Velázquez-Uncal M, Mejía-Alfaro R, Vázquez-García JC, Pérez-Padilla R et al. Pruebas de la función respiratoria: ¿cuál y a quién? Neumol Cir Tórax 2011; 70: 101-117.

  3. The European Lung Foundation (ELF) founded by the European Respiratory Society (ERS) (Consultado el 19 agosto 2012). Available in: http://www.wsd2012.european-lung-foundation.org/16770-partners.html

  4. Global Initiative for Chronic Obstruction Lung Disease (GOLD). Global Strategy for the diagnosis, management and prevention of COPD. GOLD 2011 (Consultado el 20 de agosto 2012). Available in: http://www.goldcopd.org

  5. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.

  6. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. Standardization of spirometry. Eur Respir J 2005; 26: 319-338.

  7. Puente ML, García de Pedro J. Lung function tests in clinical decision-making. Arch Bronconeumol 2012; 48: 161-169.

  8. Maio S, Sherrill DL, MacNee W, Lange P, Costabel U, Dahlen SE et al. The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction. Eur Respir J 2012; 39: 1458-1467.

  9. Roa-Castro FM, Toral-Freyre S, Roa-Castro VH, Zavala HJA, Durán de Alba LM, Herrera-Amaro BP et al. Estimaciones sobre la tendencia del asma en México para el periodo 2008-2012. An Med (Mex) 2009; 54: 16-22.

  10. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.

  11. Perez-Padilla R, Valdivia G, Muino A, López MV, Márquez MN, Montes de Oca M et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol 2006; 42: 317-325.

  12. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.

  13. Derom E, van Weel C, Liistro G, Buffels J, Schermer T, Lammers E et al. Primary care spirometry. Eur Respir J 2008; 31: 197-203.

  14. Miller MR. Spirometry in primary care. Prim Care Respir J 2009; 18: 239-240.

  15. Monteagudo M, Rodriguez-Blanco T, Parcet J, Penalver N, Rubio C, Ferrer M et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch Bronconeumol 2011; 47: 226-233.

  16. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006; 28: 945-952.

  17. Hueto J, Cebollero P, Pascal I, Cascante JA, Eguía VM, Teruel F et al. Spirometry in primary care in Navarre, Spain. Arch Bronconeumol 2006; 42: 326-331.

  18. Roberts NJ, Smith SF, Partridge MR. Why is spirometry underused in the diagnosis of the breathless patient: a qualitative study. BMC Pulm Med 2011; 11: 37.

  19. Solanes GI, Crespo LA, Giner DJ. World Spirometry Day: experience in a hospital centre. Arch Bronconeumol 2011; 47: 217.

  20. Leuppi JD, Miedinger D, Chhajed PN, Buess C, Schafroth S, Bucher HC et al. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration 2010; 79: 469-474.

  21. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006; 61: 869-873.

  22. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.




2020     |     www.medigraphic.com